Vimarsana
Biggest News Aggregation in the World

Bromide Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bromide Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bromide Injection Today - Breaking & Trending Today

Lupin : November 8, 2023 Lupin Launches Rocuronium Bromide Injection in the United States -November 10, 2023 at 04:39 pm EST - Vimarsana News

Lupin : November 8, 2023 Lupin Launches Rocuronium Bromide Injection in the United States -November 10, 2023 at 04:39 pm EST

Mumbai, Baltimore, November 08, 2023: Global pharma major Lupin Limited today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL and 100 mg/10 mL Multiple-Dose Vials,...

Caplin Steriles Ltd granted final approval from USFDA for ANDA Rocuronium Bromide Injection - Vimarsana News

Caplin Steriles Ltd granted final approval from USFDA for ANDA Rocuronium Bromide Injection

Caplin Steriles Ltd has been granted final approval from the USFDA for its ANDA Rocuronium Bromide Injection, 10 mg/mL in 5 mL and 10 mL Multi-dose Vials, a generic therapeutic equivalent version of, ZEMURON Injection, of Organon USA Inc.

Phlow Launches Key Essential Medicines To Leading Children's Hospitals To Help Alleviate Impact Of Shortages - Vimarsana News

Phlow Launches Key Essential Medicines To Leading Children's Hospitals To Help Alleviate Impact Of Shortages

The availability of these medications is an important first step demonstrating Phlow’s commitment to CHC members to provide a reliable and...

Phlow Launches Key Essential Medicines to Leading Children's Hospitals to Help Alleviate Impact of Shortages - Vimarsana News

Phlow Launches Key Essential Medicines to Leading Children's Hospitals to Help Alleviate Impact of Shortages

Children’s Hospital Coalition (CHC) encourages more children’s hospitals to join and tackle the shortage crisisRICHMOND, Va.--(BUSINESS WIRE)--Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the Child...